NADIA Sawalha is backing her Loose Women pal Jane Moore to succeed on I’m A Celebrity after it was revealed she’s in advanced talks to do the show.
If Sun columnist and broadcaster Jane, 62, does put pen to paper to become a campmate, Nadia has every faith she’ll stomach whatever hosts Ant and Dec throw her way.
Speaking exclusively to The Sun, Nadia revealed how she’s witnessed Jane’s tough streak on a number of girls’ holidays abroad.
She said: “I genuinely do not know if she’s going in or not, but if she were to go in, she will be absolutely knockout because we go on holiday and she’s petrifying.
“She’s so organised, nothing fazes her. She’ll still go out dancing if she has the worst upset stomach.
“Actually, the last time Kaye [Adams] and I and her went away, they were both so ill, but it didn’t stop her tucking into a steak and a good glass of red. So if she’s going in, I literally don’t know, she’ll be amazing.”
According to reports, Jane is ready for a new challenge after splitting from her talent agent husband Gary Farrow.
An insider told Mail Online: “She’s been separated from Gary now for two years and it’s about time she set herself a new goal, to really experience what she’s made of.
“It’s been a transformative few years for Jane and doing the show, which will be completely out of her comfort zone, is something she’s really looking forward to.”
A spokesperson for ITV said: “Any names suggested for I’m A Celebrity…Get Me Out Of Here! are speculation.”
Jan wouldn’t be the first Loose Women star to enter the jungle.
Charlene White, Janet Street Porter, Frankie Bridge, Olivia Attwood and Linda Robson have all given it a go.
Nadia has also been linked to the show in the past but has yet to feature.
Her current focus is on campaign to get thousands of women with incurable cancer access to a drug that could extend their lives.
Enhertu – which is used to treat patients like them in 25 countries including Scotland – has been denied for use on the NHS by the National Institute for Health and Care Excellence (NICE) due to its cost.
It’s estimated to be around £10,000 per patient per year in the US where it is available to cancer patients.
Nadia’s close friend Hannah Gardner, 37, whom she calls her ‘daughter’, is currently on Enhertu as part of a clinical trial that sees her also having to take a more toxic drug as part of its conditions.
So far, the mum-of-one’s tumours have responded well to the life-extending medicine, but the delay in getting onto the trial allowed her stage 4 cancer to spread.
Nadia explained why the group, which has raised £45,000 towards its target at the time of writing, is having to self-fund lawyers to contest NICE‘s decision.
Speaking from her home, she says: “Big Pharma told us that NHS England have been offered it [Enhertu] at the lowest price of anyone else that’s taken Enhertu. And so that’s NICE then, who are in charge of approving.
“I was in the [Royal] Marsden many times with Hannah and them saying, ‘oh, well, it will come through. There’s always a bit of this back and forth and it will come through’.
“You know, it’s an amazing drug. Nothing’s had this reaction since Herceptin, which we know has saved hundreds of thousands of women’s lives.
“So everybody thought it was a dead cert, but what happened is there’s something called a severity modifier; if you imagine, secondary breast cancer was in the column of a severe disease and there was a certain pot of money for that, but they moved it across the column to moderately severe. Now there is no cure for secondary breast cancer.
“So for those women to be told that their disease wasn’t severe and was only moderate and that that pot of money that was over there is now no longer available to buy this drug was just devastating.”
To donate to the campaign, click here.
